The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...

Aalto University scientists have created a laser-based treatment that uses gentle heat to stop the progression of dry macular ...

Scientists have developed a revolutionary laser treatment to prevent blindness. This non-invasive therapy uses ultra-short ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

A new approach pioneered by Aalto University scientists uses controlled warmth to trigger self-repair within retinal cells ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

A laser treatment for this common eye disease will start clinical trials in Finland next spring ––researchers hope it could be available to sufferers in as little as three years Around a third of ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...